Barrington Reaffirms Their Buy Rating on Healthequity HQY
Contents:
Data are provided ‘as is’ for informational purposes only and are not intended for trading purposes. Data may be intentionally delayed pursuant to supplier requirements. We’d like to share more about how we work and what drives our day-to-day business. Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
- Since then, HQY shares have decreased by 4.7% and is now trading at $58.75.
- Real-time quotes, advanced visualizations, backtesting, and much more.
- Jon Kessler has an approval rating of 95% among the company’s employees.
- HealthEquity saw a increase in short interest during the month of February.
- An industry with a larger percentage of Zacks Rank #1’s and #2’s will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4’s and #5’s.
It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. The company was incorporated in 2002 and is headquartered in Draper, Utah. Market Cap is calculated by multiplying the number of shares outstanding by the stock’s price. To calculate, start with total shares outstanding and subtract the number of restricted shares. Restricted stock typically is that issued to company insiders with limits on when it may be traded.Dividend YieldA company’s dividend expressed as a percentage of its current stock price. HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions.
As of February 28th, there was short interest totaling 2,990,000 shares, an increase of 7.9% from the February 13th total of 2,770,000 shares. Based on an average daily volume of 767,400 shares, the short-interest ratio is presently 3.9 days. The detailed multi-page Analyst report does an even deeper dive on the company’s vital statistics. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500. HealthEquity, Inc. is engaged in providing technology-enabled services platforms that helps consumers to make healthcare saving and spending decisions. Currently, the analyst consensus on Healthequity is a Strong Buy with an average price target of $80.71, which is a 39.88% upside from current levels.
Trading Services
This means that over the past quarter there has been an increase of insiders selling their shares of HQY in relation to earlier this year. I think HQY stock can ride the interest rate tailwind higher, and don’t think a $100 stock price is out of the question. That would be about a 22.5x multiple on the current FY25 EBITDA consensus.
HealthEquity has been upgraded to a Zacks Rank #2 , reflecting growing optimism about the company’s earnings prospects. The Zacks Medical – Services industry is growing on digital healthcare adoption. The Zacks Industry Rank assigns a rating to each of the 265 X Industries based on their average Zacks Rank.
Let’s start up with the current stock price of HealthEquity Inc. , which is $52.44 to be very precise. The Stock rose vividly during the last session to $59.74 after opening rate of $58.60 while the lowest price it went was recorded $52.27 before closing at $61.68. Zacks Earnings ESP looks to find companies that have recently seen positive earnings estimate revision activity. The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season.
Per-Share Earnings, Actuals and Estimates
The scores are based on the trading styles of Value, Growth, and Momentum. There’s also a VGM Score (‘V’ for Value, ‘G’ for Growth and ‘M’ for Momentum), which combines the weighted average of the individual style scores into one score. The company is scheduled to release its fiscal fourth-quarter earnings on Mar 21. A valuation method that multiplies the price of a company’s stock by the total number of outstanding shares.
Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -14.93%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -21.66%, alongside a downfall of -2.29% for the period of the last 12 months. The shares increased approximately by -20.55% in the 7-day charts and went down by -13.08% in the period of the last 30 days. Common stock shares were lifted by -18.89% during last recorded quarter. Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.
HealthEquity’s stock was trading at $61.64 at the start of the year. Since then, HQY shares have decreased by 4.7% and is now trading at $58.75. Investchronicle.com is an Economic news website, which offers broad information about the Stock markets and Equities. The major emphasis of this platform is to present, the most practical recommendation for public and private capital sharing, both in the form of updates and detailed analysis.
The consensus among Wall Street equities research analysts is that investors should “buy” HQY shares. High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
HealthEquity does not have a long track record of dividend growth. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist.
HealthEquity stock price target raised to $62 from $52 at Deutsche Bank
Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index quotes are real-time. Verify your identity, personalize the content you receive, or create and administer your account. Paris covers the Services sector, focusing on stocks such as Grand Canyon Education, H&R Block, and Universal Technical Institute. I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours.
HealthEquity (HQY) Set to Announce Quarterly Earnings on Tuesday – MarketBeat
HealthEquity (HQY) Set to Announce Quarterly Earnings on Tuesday.
Posted: Tue, 14 Mar 2023 05:59:03 GMT [source]
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated. Of the $22 billion in assets that HQY holds for customers, over $14 billion is in cash.
Key Data
To see all exchange delays and terms of use please see Barchart’s disclaimer. One share of HQY stock can currently be purchased for approximately $58.75. HealthEquity’s stock is owned by a variety of institutional and retail investors. Sign-up to receive the latest dukascopy forex broker, dukascopy review, dukascopy information news and ratings for HealthEquity and its competitors with MarketBeat’s FREE daily newsletter. The P/E ratio of HealthEquity is -84.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
69.0% of employees surveyed would recommend working at HealthEquity to a friend. HealthEquity has a short interest ratio (“days to cover”) of 3.9, which is generally considered an acceptable ratio of short interest to trading volume. MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation. Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports. HealthEquity witnesses solid growth in HSAs, besides recording robust performances in majority of its segments, in the second quarter of fiscal 2023.
Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. 10 Wall Street equities research analysts have issued “buy,” “hold,” and “sell” ratings for HealthEquity in the last year. There are currently 2 hold ratings and 8 buy ratings for the stock.
Tech companies have made a lot of headlines with their layoffs, and it’s also trickled into other industries as well. That said, HQY’s business has held up reasonably well in past recessions, as people began to save more. Some of that is due to HQY locking in some rates via a laddering strategy and members moving some money into investments. However, where short-term https://day-trading.info/ rates are now and with the Fed recently indicating that it would get more aggressive with rate hikes, that number still seems too low. © 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed.
As such, I’m looking for strong results and at the very least reiterated guidance, with a pretty good chance that it raises guidance. The HSA market has been growing nicely for quite some time now, and deposits are projected to continue to grow at about a 10% annual pace . At the same time, participants are saving more than they are spending, which is leading to higher levels of assets under custodianship.
HealthEquity, Inc. provides range of solutions for managing health care accounts. The firm’s offers its solutions for employers, health plans, brokers, consultants and financial advisors. Its services include HAS, FSA, HRA, DCRA, 401, Commuter, COBRA and HIA. It also offers products like healthcare saving and spending platform, health savings accounts, investment advisory services, reimbursement arrangements, and healthcare incentives.
We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive. A stock’s beta measures how closely tied its price movements have been to the performance of the overall market. Given the continued march higher for interest rates, I feel the company is still being conservative.
The company was founded by Stephen D. Neeleman on September 18, 2002 and is headquartered in Draper, UT. The firm’s offers its solutions for employers, health planbs, brokers, consultants and financial advisors. The firm’s offers its solutions for employers, health plans, brokers, consultants and financial advisors. HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool.
Recent Comments